1. Home
  2. ICCM vs HNNA Comparison

ICCM vs HNNA Comparison

Compare ICCM & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCM
  • HNNA
  • Stock Information
  • Founded
  • ICCM 2006
  • HNNA 1989
  • Country
  • ICCM Israel
  • HNNA United States
  • Employees
  • ICCM N/A
  • HNNA N/A
  • Industry
  • ICCM
  • HNNA Investment Managers
  • Sector
  • ICCM
  • HNNA Finance
  • Exchange
  • ICCM Nasdaq
  • HNNA Nasdaq
  • Market Cap
  • ICCM 74.7M
  • HNNA 82.4M
  • IPO Year
  • ICCM N/A
  • HNNA N/A
  • Fundamental
  • Price
  • ICCM $1.11
  • HNNA $10.35
  • Analyst Decision
  • ICCM Strong Buy
  • HNNA
  • Analyst Count
  • ICCM 1
  • HNNA 0
  • Target Price
  • ICCM $2.50
  • HNNA N/A
  • AVG Volume (30 Days)
  • ICCM 352.8K
  • HNNA 10.3K
  • Earning Date
  • ICCM 03-27-2025
  • HNNA 05-07-2025
  • Dividend Yield
  • ICCM N/A
  • HNNA 5.31%
  • EPS Growth
  • ICCM N/A
  • HNNA 75.66
  • EPS
  • ICCM N/A
  • HNNA 1.12
  • Revenue
  • ICCM $3,291,000.00
  • HNNA $33,210,000.00
  • Revenue This Year
  • ICCM $75.63
  • HNNA N/A
  • Revenue Next Year
  • ICCM $69.36
  • HNNA N/A
  • P/E Ratio
  • ICCM N/A
  • HNNA $9.36
  • Revenue Growth
  • ICCM 1.92
  • HNNA 38.27
  • 52 Week Low
  • ICCM $0.48
  • HNNA $6.60
  • 52 Week High
  • ICCM $1.66
  • HNNA $13.88
  • Technical
  • Relative Strength Index (RSI)
  • ICCM 35.03
  • HNNA 37.97
  • Support Level
  • ICCM $1.04
  • HNNA $10.35
  • Resistance Level
  • ICCM $1.25
  • HNNA $10.90
  • Average True Range (ATR)
  • ICCM 0.09
  • HNNA 0.38
  • MACD
  • ICCM -0.04
  • HNNA 0.04
  • Stochastic Oscillator
  • ICCM 14.29
  • HNNA 63.82

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

Share on Social Networks: